INFLIXIMAB , TOCILIZUMAB , Cosentyx 300 mg solution for injection in pre-filled pen, ADALIMUMAB
APHP 240614
Phase 2 small_molecule active
Quick answer
INFLIXIMAB , TOCILIZUMAB , Cosentyx 300 mg solution for injection in pre-filled pen, ADALIMUMAB for TAkayasu ARteritiS is a Phase 2 program (small_molecule) at Pari Pharma GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pari Pharma GmbH
- Indication
- TAkayasu ARteritiS
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active